Kadmon Holdings Llc (KDMN) 8.00 $KDMN Kadmon Initiates

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kadmon Holdings Llc (KDMN) 8.00 $KDMN

Kadmon Initiates Placebo-Controlled Phase 2 Clinical Trial Evaluating KD025 in Psoriasis
BusinessWire - Wed Sep 21, 3:47PM CDT
Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a double-blind, placebo-controlled Phase 2 clinical trial of KD025, the Company's oral inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), in moderate to severe chronic plaque psoriasis. The dose-finding study examines KD025 administered at four doses: 200 mg once daily (QD), 200 mg twice daily (BID), 400 mg QD and 600 mg QD (administered as 400 mg in the morning and 200 mg in the evening) compared to matching placebo BID for 16 weeks in approximately 150 patients in the United States.
KDMN: 8.00 (+0.24)

Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Chronic Graft-Versus Host Disease
BusinessWire - Wed Sep 21, 3:04PM CDT
Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a Phase 2 clinical trial of KD025, the Company's rho-associated coiled-coil kinase 2 (ROCK2) inhibitor, for the treatment of chronic graft-versus-host disease (cGVHD). The randomized, open-label, 24-week study examines the safety, tolerability and activity of KD025 dosed at 200 mg once daily (QD), 200 mg twice daily (BID) or 400 mg QD in 48 cGVHD patients in the United States.
KDMN: 8.00 (+0.24)

Kadmon Reports Financial and Operational Results for the Three and Six Months Ended June 30, 2016
BusinessWire - Wed Sep 07, 3:01PM CDT
Kadmon Holdings, Inc. (NYSE:KDMN), a fully integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need, today reported its financial and operational results for the three and six months ended June 30, 2016.
KDMN: 8.00 (+0.24)

Kadmon to Present at Two Upcoming Investor Conferences
BusinessWire - Wed Sep 07, 8:00AM CDT
Kadmon Holdings, Inc. (NYSE:KDMN), today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present an overview of the Company and its clinical programs at two upcoming investor conferences in New York:
KDMN: 8.00 (+0.24)

Kadmon Initiates Phase 2 Clinical Trial Evaluating Tesevatinib in Glioblastoma
BusinessWire - Mon Aug 29, 8:00AM CDT
Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a Phase 2 clinical trial of tesevatinib, the Company's oral tyrosine kinase inhibitor, for the treatment of recurrent glioblastoma. The open-label, multicenter study examines tesevatinib monotherapy administered at 300 mg once daily in up to 40 patients in the United States.
KDMN: 8.00 (+0.24)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Otis Sets Record, Reports Solid Q3 Results

Updated Category News Views 88

Climbing the Heights: Otis' Record-Breaking Feat The news just hit: Otis Worldwide Corporation managed to snatch the Guinness World Records™ title for the tallest elevator, sitting pretty in the Tianjin 117 building. How about that for a jaw-dropper in vertical mobility? Elevators might seem like the unsung heroes of modern skyscrapers, but when you’re making it into...

Continue Reading
Algolia Teams Up with Orange for AI-Driven Billing Support

Updated Category News Views 5

In the Thick of AI Integration with Orange Group Look who's making waves with AI—Algolia, that’s who! They’re in cahoots with Orange Group to sprinkle a bit of artificial intelligence magic over billing and account support. It might sound like a mundane corner of the business world, but don't let the monotony fool you. Algolia's collaboration with Orange is set to...

Continue Reading
Freddy's Rolls Out Value Menu in Test Markets

Updated Category News Views 121

Freddy's Value Experiment Spices Up the Fast-Food Game Wichita’s own Freddy's Frozen Custard & Steakburgers is stepping into the ring with a fresh strategy: an Everyday Value Menu. It’s quite the play, and it’s only going down in select markets. I gotta admit, the move is intriguing. These guys are taking a calculated shot, testing the waters in Arizona, Colorado,...

Continue Reading
Mohegan Sun Arena's $30M Overhaul Elevates Experiences

Updated Category News Views 20

Mohegan Sun Aims for New Heights with Major Overhaul Tuck into this: Mohegan Sun Arena, that entertainment juggernaut nestled in Montville, is gearing up for a massive $30 million facelift. You're talking all-new seating, cutting-edge concessions, and premium hospitality that puts other venues to shame. Over Two Decades of Entertainment Excellence This isn’t just...

Continue Reading
Geographic Solutions' New AI-Integrative Workforce Tool Unveiled

Updated Category News Views 89

Revamping Employment Landscapes with AI Geographic Solutions has just rolled out their latest powerhouse, Version 25 of the VOS Sapphire AI+, and let me tell you, it's got bells and whistles that could make even the savviest techie raise an eyebrow. This isn't just another software update; it's a full-bodied attempt to inject a little 21st-century magic into the workforce...

Continue Reading
UnaSource Teams with CSA for a Strategic Partnership

Updated Category News Views 98

A Strategic Collaboration in Surgery Centers In a bid to elevate its standing, UnaSource Surgery Center has partnered with Constitution Surgery Alliance (CSA), a move that seems carefully calculated to take advantage of the current trends in the ambulatory surgery center (ASC) landscape. From the get-go, this is not just any run-of-the-mill partnership; it’s got the...

Continue Reading
Datavations Unveils Test Tracker for Home Improvement

Updated Category News Views 54

Unearthing the Strategic Gold Datavations has launched something that could be a real game-changer for home improvement suppliers—a tool called the Store Test Tracker. This thing zeros in on limited-distribution SKU tests happening in the giant playgrounds of Home Depot, Lowe's, and Menards. You think small-scale trials don't matter? Buckle up, because sometimes the...

Continue Reading
PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 49

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Bank Expert Shares Tips for Effortless Checking Setup

Updated Category News Views 0

Streamlining Your Checking Account Setup Tossing out the right prep can turn opening a checking account from a headache to a breeze. Banking luminary Abigail White spills the beans in a HelloNation piece, shedding light on how getting your ducks in a row with documents and features puts you in the driver’s seat of financial well-being. The Basics: Identification and...

Continue Reading
Colorado Upholds Fair Play: Prop 134 Passed

Updated Category News Views 71

Proposition 134: Leveling the Playing Field Here we go again, folks, another state digs in its heels on the issue of fairness in sports. This time, it's Colorado stepping into the spotlight, tipping the scales with Proposition 134. It's a move that keeps girls' sports strictly for girls, leaving no room for ambiguity when it comes to team designations. More than 1.25...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercer International Inc. Achieves Robust EBITDA Growth in 2024

Updated Category News Views 301

Mercer International Inc. Sees Impressive Growth in 2024 Mercer International Inc. (NASDAQ: MERC) has reported significant financial results for the fourth quarter and the year ended in 2024. The company achieved an Operating EBITDA of $99.2 million in Q4, a substantial increase from $50.5 million in the previous quarter and a notable leap from $21.1 million in the same...

Continue Reading
Dar Al Arkan Set to Launch Landmark Manhattan Masterplan

Updated Category News Views 188

Dar Al Arkan to Unveil the Manhattan Masterplan Dar Al Arkan, notably a leader in real estate development, is set to roll out an extraordinary masterplan known as Manhattan. Located on King Abdulaziz Road, this promising project is tailored to become a landmark destination that merges luxury living with modern conveniences. The Vision Behind Manhattan Covering a vast area...

Continue Reading
Sysorex Stock Hits Record Low: What's Next for Investors?

Updated Category News Views 187

Sysorex Global (XTIA) faced a catastrophic stock decline, hitting a jaw-dropping 52-week low of $0.19, which translated to a staggering drop of -98.44% over the last year. This collapse has sent shockwaves through trading desks, igniting skepticism among investors and analysts alike about the company's viability in the rapidly changing tech landscape. Market Turmoil:...

Continue Reading
Rogers Communications Makes Major Acquisition in Sports Sector

Updated Category News Views 562

Rogers Communications Acquires Majority Interest in MLSE Rogers Communications Inc. (NYSE: RCI) has recently made waves by announcing its plan to acquire a substantial stake in Maple Leaf Sports & Entertainment (MLSE) for around $3.46 billion. This significant acquisition is a key step for Rogers as they expand their influence in the sports and entertainment sector....

Continue Reading
Celebrating a Decade of Innovations in Sleep Health Research

Updated Category News Views 193

Sleep Health: A Decade of Impact in Sleep Research The National Sleep Foundation celebrates the remarkable 10th anniversary of its journal, Sleep Health, a publication dedicated to the exploration of sleep’s influence on public health. Since its inception, this journal has served as a key resource for professionals in the field, promoting the understanding of sleep's...

Continue Reading